Koyfin Home > Directory > Health Care > Adma Biologics > Gross Profit

Adma Biologics Gross Profit Chart (ADMA)

Adma Biologics annual/quarterly Gross Profit from 2011 to 2020. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Adma Biologics Gross Profit for the quarter ending June 06, 2020 was $-6m a 87.85% decrease of -5m year over year
  • Adma Biologics Gross Profit for the last 12 months ending June 06, 2020 was $-13m a -38.63% increase of 5m year over year
  • Adma Biologics Annual Gross Profit for 2019 was $-10m a -148.24% increase of 15m from 2018
  • Adma Biologics Annual Gross Profit for 2018 was $-25m a 46.83% decrease of -12m from 2017
  • Adma Biologics Annual Gross Profit for 2017 was $-13m a 132.08% decrease of -18m from 2016
Other Income Statement Metrics:
  • Adma Biologics EBITDA for the quarter ending December 12, 2018 was $-16m a -0.51% increase of 0m year over year
  • Adma Biologics Net Income for the quarter ending December 12, 2018 was $-18m a 1.20% decrease of 0m year over year
  • Adma Biologics Total Revenue for the quarter ending September 09, 2018 was $4m a -183.74% decrease of -8m year over year
View Chart On Koyfin

Quarterly ADMA Gross Profit Data

06/2020$-6m
03/2020$-7m
12/2019$0m
09/2019$-1m
06/2019$-4m
03/2019$-6m
12/2018$-7m
09/2018$-5m
06/2018$-5m
03/2018$-8m

Annual ADMA Gross Profit Data

2019$-10m
2018$-25m
2017$-13m
2016$4m
2015$3m
2014$2m
2013$1m
2012$0m
2011$1m